SCHEMBL8912962

SCHEMBL8912962

C=CC(=O)Oc1c[nH]nc1-c1cccc(F)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
XPO1 O14980 1/20 0.38
JAK3 P52333 2/20 0.36
JAK2 O60674 1/20 0.36
MAP2K4 P45985 1/20 0.36
NOTUM Q6P988 1/20 0.35
PIN1 Q13526 1/20 0.35
BTK Q06187 1/20 0.35
IDO1 P14902 1/20 0.35
HTR7 P34969 1/20 0.34
GRK6 P43250 1/20 0.34
PDE4B Q07343 4/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
KMO O15229 1/20 0.34
MAP2K7 O14733 1/20 0.34
AURKA O14965 1/20 0.34
PTGER2 P43116 1/20 0.33
HPGDS O60760 1/20 0.33
CHUK O15111 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8915190 0.84 THRB (0.39) JAK3MAP2K7AURKAHPGDS
SCHEMBL20342995 0.76 ESR2 (0.42) PTGER2
SCHEMBL18472808 0.74 PTGER2 (0.41) PIN1PTGER2
SCHEMBL28214966 0.72 DCLRE1B (0.47) JAK3JAK2MAP2K4NOTUMPIN1
SCHEMBL8912951 0.71 JAK3 (0.40) JAK3JAK2MAP2K4NOTUMPIN1
SCHEMBL30543222 0.71 ESR1 (0.49)
SCHEMBL5634217 0.71 ESR1 (0.49)
SCHEMBL8913209 0.71 NOTUM (0.41) JAK3JAK2NOTUMIDO1HTR7
SCHEMBL8912957 0.70 TDO2 (0.46) XPO1MAP2K4PIN1AURKA
SCHEMBL8912952 0.70 TDO2 (0.46) XPO1MAP2K4PIN1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5606073-A INTERMEDIATES FOR ADENOSINE ANTAGONISTS EISAI CO., LTD. (JP) 1997-02-25 US disclosed
US-5541213-A ADENOSINE A1 RECEPTOR ANTAGONISTS, TREATMENT OF KIDNEY DISORDERS EISAI CO., LTD. (JP) 1996-07-30 US disclosed
EP-0630894-A1 Propenoic acid derivatives as adenosine A1 antagonists Eisai Co., Ltd. (JP) 1994-12-28 EP disclosed